GAP UP:

$AUPH: “Aurinia Announces Positive AURORA Phase 3 Trial Results Demonstrating Voclosporin Superiority Over Standard of Care in Lupus Nephritis”

Support: 16.50, 15.50

Resistance: 18.00, 20.00

$BNGO: “Breakthrough Findings in Leukemias Presented at ASH 2019 Demonstrate Bionano Saphyr’s Potential to Replace All Cytogenetic Methods and Show Additional Clinical Utility”

Support: 1.15, 1.05, 1.00

Resistance: 1.25, 1.35

$SEAC: “SeaChange International, Inc. today reported third quarter fiscal 2020 revenue of $20.5 million and net income of $2.1 million, or $0.06 per basic share, compared to third quarter fiscal 2019 revenue of $18.6 million and a net loss of $3.8 million, or $0.11 per basic share”

Support: 4.00

Resistance: 4.30, 4.50

Others: $ACAD $EXPR $DLTH

GAP DOWN:

$SAGE: “Sage Therapeutics's Stock Plunges After Depression Treatment Study Fails Primary Endpoint”

Support: 53.00, 52.60

Resistance: 58.00, 62.00

$HOME: "At Home's Stock Plummets On Big Forecast Miss”

Support: 4.75

Resistance: 5.00, 5.25

Others: $ESTC $MIK

PREVIOUS DAY MOVERS:

$PTGX $AVXL $KOD $LJPC $IBIO

submitted by /u/mtmtrader
[comments]



Source link

قالب وردپرس

LEAVE A REPLY

Please enter your comment!
Please enter your name here